Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
New words:
ablation, Anderton, anterior, Bateman, BLTI, capsulotomy, cataract, collaterize, Delaware, Dr, evidenced, eye, Federico, focused, fullest, Haefner, Indemnification, indemnify, Keith, Lobel, Marilyn, medicine, milestone, oculase, oculoplasty, ophthalmology, orbit, partly, permitted, Pignatelli, pretrial, restricted, resurfacing, secondary, skin, stage, symbol, therewith
Removed:
conference, cooperate, covenant, default, earned, fourteen, obtained, profitable, publicly, reach, regular, responded
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 4.1 Form of Warrant to Purchase Common Stock of Biolase Technology, Inc.
- 10.1 Form of Indemnification Agreement
- 10.2 Fourth Amendment to Credit Agreement Dated November 4, 2005
- 10.3 Security Agreement Dated November 4, 2005
- 31.1 Section 302 Certification of Robert E. Grant
- 31.2 Section 302 Certification of John W. Hohener
- 32.1 Section 906 Certification of Robert E. Grant
- 32.2 Section 906 Certification of John W. Hohener
Related press release
BIOL similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Robert E. Grant, President and Chief Executive Officer of BIOLASE Technology, Inc. (the “Company”), hereby certify that to the best of my knowledge:
(1) | This quarterly report on Form 10-Q for the quarter ended September 30, 2005 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: November 9, 2005 | /s/ ROBERT E. GRANT | |||||
Robert E. Grant President and Chief Executive Officer |
* | This certificate accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934. |